Literature DB >> 21421142

Mohs surgery for squamous cell carcinoma.

Daniel Belkin1, John A Carucci.   

Abstract

Cutaneous squamous cell carcinoma (SCC) is the second most common human cancer and can behave aggressively. Mohs micrographic surgery offers the highest cure rates for high-risk SCCs and is particularly useful for SCCs on challenging anatomic sites.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2011        PMID： 21421142     DOI： 10.1016/j.det.2011.02.006

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN： 0733-8635            Impact factor:   3.478


  7 in total

Review 1.  Interleukin-22 and Cyclosporine in Aggressive Cutaneous Squamous Cell Carcinoma.

Authors:  Alexis L Santana; Diane Felsen; John A Carucci
Journal:  Dermatol Clin       Date:  2017-01       Impact factor: 3.478

2.  Squamous cell carcinoma of the skin: Emerging need for novel biomarkers.

Authors:  Atte Kivisaari; Veli-Matti Kähäri
Journal:  World J Clin Oncol       Date:  2013-11-10

3.  Omental transplantation improves surgical outcome of large squamous cell carcinoma: A case report.

Authors:  Xianan Li; Zhengxiao Ouyang; Shuo Yang; Zanjing Zhai; Haowei Li; Zhong-Cheng Kang; Zan Li
Journal:  Oncol Lett       Date:  2015-03-31       Impact factor: 2.967

Review 4.  Management of High-Risk Squamous Cell Carcinoma of the Skin.

Authors:  Teresa Fu; Sumaira Z Aasi; S Tyler Hollmig
Journal:  Curr Treat Options Oncol       Date:  2016-07

5.  Effective treatment of squamous cell carcinomas with ingenol mebutate gel in immunologically intact SKH1 mice.

Authors:  Sarah-Jane Cozzi; Thuy T Le; Steven M Ogbourne; Cini James; Andreas Suhrbier
Journal:  Arch Dermatol Res       Date:  2012-08-08       Impact factor: 3.017

6.  Basosquamous Carcinoma: A Commentary.

Authors:  Christina Fotiadou; Zoe Apalla; Elizabeth Lazaridou
Journal:  Cancers (Basel)       Date:  2021-12-06       Impact factor: 6.639

Review 7.  Advances in the management of cutaneous squamous cell carcinoma.

Authors:  Sonal A Parikh; Vishal A Patel; Desiree Ratner
Journal:  F1000Prime Rep       Date:  2014-08-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.